Clinical Trials Directory

Trials / Completed

CompletedNCT00370786

Effect of Intravitreal Bevacizumab on Non -Age-Related Macular Degeneration (AMD) Related Choroidal Neovascularization (CNV)

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
31 (actual)
Sponsor
Shahid Beheshti University of Medical Sciences · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

To evaluate the effect of bevacizumab for treatment of non-AMD choroidal neovascularization (CNV); eg:angioid streaks, ocular histoplasmosis, high myopia, idiopathic,etc

Conditions

Interventions

TypeNameDescription
DRUGbevacizumab

Timeline

Start date
2005-11-01
Primary completion
2007-11-01
Completion
2008-02-01
First posted
2006-09-01
Last updated
2008-07-11

Locations

1 site across 1 country: Iran

Source: ClinicalTrials.gov record NCT00370786. Inclusion in this directory is not an endorsement.

Effect of Intravitreal Bevacizumab on Non -Age-Related Macular Degeneration (AMD) Related Choroidal Neovascularization ( (NCT00370786) · Clinical Trials Directory